|
Muniz-Castrillo M, Blaya Boluda N, Garcia-Torralba E, Jimenez-Fonseca P, Gonzalez Del Rey C, Balbin M, Luengo-Gil G, Ayala de la Pena F, Esteban Gonzalez E, Carmona-Bayonas A. Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clin Transl Oncol. 2025 May 4. doi: 10.1007/s12094-025-03933-x. Online ahead of print. PubMed PMID: 40319412.
AÑO: 2025; IF: 2.5
|
40319412
|
Vinuela-Beneitez MC, Iglesias Perez C, Ortega Moran L, Garcia Escobar I, Cacho Lavin D, Porta I Balanya R, Garcia Adrian S, Carmona Campos M, Benitez Lopez G, Santiago Crespo JA, Lobo de Mena M, Perez Altozano J, Gallardo Diaz E, Tejerina Peces J, Ochoa Rivas P, Ortiz Morales MJ, Castellon Rubio VE, Diez Pedroche C, Rosales Sueiro M, Goncalves F, Sanchez-Canovas M, Ruiz MA, Munoz-Langa J, Perez Segura P, de Castro EM, Carmona-Bayonas A, Jimenez-Fonseca P, Munoz Martin AJ. External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI). Clin Transl Oncol. 2025 Oct;27(10):4031-4039. doi: 10.1007/s12094-025-03890-5. Epub 2025 Apr 26. PubMed PMID: 40287561; PubMed Central PMCID: PMC12460363.
AÑO: 2025; IF: 2.5
|
|
Capdevila J, Hernando J, Molina-Cerrillo J, Benavent Vinuales M, Garcia-Carbonero R, Teule A, Custodio A, Jimenez-Fonseca P, Lopez C, Hierro C, Carmona-Bayonas A, Alonso V, Llanos M, Sevilla I, Garcia-Alvarez A, Alonso-Gordoa T, Gallego Jimenez I, Anton-Pascual B, Modrego Sanchez A, Grande E. Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914). Clin Cancer Res. 2025 Nov 14;31(22):4655-4663. doi: 10.1158/1078-0432.CCR-25-2143. PubMed PMID: 40938918; PubMed Central PMCID: PMC12616244.
AÑO: 2025; IF: 10.2
|
|
Navarro P, Beato C, Rodriguez-Moreno JF, Ruiz-Llorente S, Mielgo X, Pineda E, Navarro M, Bruixola G, Grazioso TP, Viudez A, Fuster J, Nogueron E, Mediano MD, Balana C, Mendez C, Rodriguez RM, Del Barco Berron S, Gongora B, Carmona-Bayonas A, Garcia-Donas J. Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clin Transl Oncol. 2025 Jun;27(6):2719-2730. doi: 10.1007/s12094-024-03745-5. Epub 2024 Nov 1. PubMed PMID: 39485597.
AÑO: 2025; IF: 2.5
|
|
Vedovati MC, Munoz Martin AJ, Giustozzi M, Jimenez-Fonseca P, Becattini C, Martinez Del Prado MP, Dentali F, Huisman MV, Cohen AT, Bauersachs R, Carmona-Bayonas A, Agnelli G. Derivation and validation of the Caravaggio score for the risk stratification for recurrence in patients with cancer-associated venous thromboembolism. Eur J Intern Med. 2025 Jul;137:67-72. doi: 10.1016/j.ejim.2025.04.016. Epub 2025 Apr 18. PubMed PMID: 40253230.
AÑO: 2025; IF: 6.1
|